nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisatracurium Besylate—Generalised erythema—Cisplatin—peripheral nervous system neoplasm	0.0756	0.0786	CcSEcCtD
Cisatracurium Besylate—Hypoxemia—Tretinoin—peripheral nervous system neoplasm	0.0486	0.0505	CcSEcCtD
Cisatracurium Besylate—Hypoxemia—Isotretinoin—peripheral nervous system neoplasm	0.0486	0.0505	CcSEcCtD
Cisatracurium Besylate—Hypoxemia—Alitretinoin—peripheral nervous system neoplasm	0.0369	0.0383	CcSEcCtD
Cisatracurium Besylate—Brain oedema—Tretinoin—peripheral nervous system neoplasm	0.0341	0.0355	CcSEcCtD
Cisatracurium Besylate—Brain oedema—Isotretinoin—peripheral nervous system neoplasm	0.0341	0.0355	CcSEcCtD
Cisatracurium Besylate—Brain oedema—Alitretinoin—peripheral nervous system neoplasm	0.0259	0.0269	CcSEcCtD
Cisatracurium Besylate—Doxacurium chloride—BCHE—peripheral nervous system neoplasm	0.0195	0.515	CrCbGaD
Cisatracurium Besylate—Mivacurium—BCHE—peripheral nervous system neoplasm	0.0184	0.485	CrCbGaD
Cisatracurium Besylate—Hypoxia—Tretinoin—peripheral nervous system neoplasm	0.0154	0.016	CcSEcCtD
Cisatracurium Besylate—Hypoxia—Isotretinoin—peripheral nervous system neoplasm	0.0154	0.016	CcSEcCtD
Cisatracurium Besylate—Azotaemia—Vincristine—peripheral nervous system neoplasm	0.0134	0.0139	CcSEcCtD
Cisatracurium Besylate—Hypoxia—Alitretinoin—peripheral nervous system neoplasm	0.0116	0.0121	CcSEcCtD
Cisatracurium Besylate—Cardiovascular disorder—Isotretinoin—peripheral nervous system neoplasm	0.0111	0.0115	CcSEcCtD
Cisatracurium Besylate—Cardiovascular disorder—Tretinoin—peripheral nervous system neoplasm	0.0111	0.0115	CcSEcCtD
Cisatracurium Besylate—Wheezing—Tretinoin—peripheral nervous system neoplasm	0.00948	0.00985	CcSEcCtD
Cisatracurium Besylate—Wheezing—Isotretinoin—peripheral nervous system neoplasm	0.00948	0.00985	CcSEcCtD
Cisatracurium Besylate—Cardiovascular disorder—Alitretinoin—peripheral nervous system neoplasm	0.00842	0.00875	CcSEcCtD
Cisatracurium Besylate—Laryngospasm—Etoposide—peripheral nervous system neoplasm	0.00773	0.00804	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Topotecan—peripheral nervous system neoplasm	0.00738	0.00767	CcSEcCtD
Cisatracurium Besylate—Wheezing—Alitretinoin—peripheral nervous system neoplasm	0.00718	0.00747	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Topotecan—peripheral nervous system neoplasm	0.00679	0.00706	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Tretinoin—peripheral nervous system neoplasm	0.00674	0.007	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Isotretinoin—peripheral nervous system neoplasm	0.00674	0.007	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Melphalan—peripheral nervous system neoplasm	0.00665	0.00691	CcSEcCtD
Cisatracurium Besylate—Cardiovascular disorder—Etoposide—peripheral nervous system neoplasm	0.00657	0.00683	CcSEcCtD
Cisatracurium Besylate—Wheezing—Cisplatin—peripheral nervous system neoplasm	0.00612	0.00636	CcSEcCtD
Cisatracurium Besylate—Bronchospasm—Isotretinoin—peripheral nervous system neoplasm	0.00602	0.00626	CcSEcCtD
Cisatracurium Besylate—Bronchospasm—Tretinoin—peripheral nervous system neoplasm	0.00602	0.00626	CcSEcCtD
Cisatracurium Besylate—Bronchospasm—Melphalan—peripheral nervous system neoplasm	0.00594	0.00618	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Alitretinoin—peripheral nervous system neoplasm	0.0051	0.00531	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Vincristine—peripheral nervous system neoplasm	0.00492	0.00511	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Melphalan—peripheral nervous system neoplasm	0.00475	0.00494	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Cisplatin—peripheral nervous system neoplasm	0.00473	0.00491	CcSEcCtD
Cisatracurium Besylate—Bronchospasm—Alitretinoin—peripheral nervous system neoplasm	0.00456	0.00474	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Vincristine—peripheral nervous system neoplasm	0.00456	0.00474	CcSEcCtD
Cisatracurium Besylate—Flushing—Tretinoin—peripheral nervous system neoplasm	0.00455	0.00473	CcSEcCtD
Cisatracurium Besylate—Flushing—Isotretinoin—peripheral nervous system neoplasm	0.00455	0.00473	CcSEcCtD
Cisatracurium Besylate—Flushing—Melphalan—peripheral nervous system neoplasm	0.00449	0.00467	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Topotecan—peripheral nervous system neoplasm	0.00448	0.00466	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Topotecan—peripheral nervous system neoplasm	0.00446	0.00464	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Topotecan—peripheral nervous system neoplasm	0.00445	0.00463	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Tretinoin—peripheral nervous system neoplasm	0.00445	0.00462	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Isotretinoin—peripheral nervous system neoplasm	0.00445	0.00462	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Melphalan—peripheral nervous system neoplasm	0.00437	0.00454	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Melphalan—peripheral nervous system neoplasm	0.00436	0.00453	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Etoposide—peripheral nervous system neoplasm	0.00433	0.0045	CcSEcCtD
Cisatracurium Besylate—Erythema—Tretinoin—peripheral nervous system neoplasm	0.00427	0.00443	CcSEcCtD
Cisatracurium Besylate—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.00427	0.00443	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Etoposide—peripheral nervous system neoplasm	0.00398	0.00414	CcSEcCtD
Cisatracurium Besylate—Angioedema—Topotecan—peripheral nervous system neoplasm	0.00393	0.00408	CcSEcCtD
Cisatracurium Besylate—Flushing—Dactinomycin—peripheral nervous system neoplasm	0.00372	0.00386	CcSEcCtD
Cisatracurium Besylate—Convulsion—Tretinoin—peripheral nervous system neoplasm	0.0037	0.00384	CcSEcCtD
Cisatracurium Besylate—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.0037	0.00384	CcSEcCtD
Cisatracurium Besylate—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.00368	0.00383	CcSEcCtD
Cisatracurium Besylate—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.00368	0.00383	CcSEcCtD
Cisatracurium Besylate—Cardiovascular disorder—Epirubicin—peripheral nervous system neoplasm	0.00368	0.00383	CcSEcCtD
Cisatracurium Besylate—Convulsion—Melphalan—peripheral nervous system neoplasm	0.00365	0.00379	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.00364	0.00378	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.00361	0.00375	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.00361	0.00375	CcSEcCtD
Cisatracurium Besylate—Bronchospasm—Etoposide—peripheral nervous system neoplasm	0.00356	0.0037	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.00356	0.0037	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Vincristine—peripheral nervous system neoplasm	0.00352	0.00366	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00351	0.00365	CcSEcCtD
Cisatracurium Besylate—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.00349	0.00362	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00348	0.00362	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00348	0.00362	CcSEcCtD
Cisatracurium Besylate—Flushing—Alitretinoin—peripheral nervous system neoplasm	0.00345	0.00358	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.00344	0.00358	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00344	0.00357	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.00341	0.00355	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.00341	0.00355	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.00341	0.00354	CcSEcCtD
Cisatracurium Besylate—Cardiovascular disorder—Doxorubicin—peripheral nervous system neoplasm	0.00341	0.00354	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.0034	0.00353	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.0034	0.00353	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.00338	0.00352	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.00338	0.00352	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Alitretinoin—peripheral nervous system neoplasm	0.00337	0.0035	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.00335	0.00349	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.00334	0.00347	CcSEcCtD
Cisatracurium Besylate—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.00325	0.00338	CcSEcCtD
Cisatracurium Besylate—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.00325	0.00338	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Vincristine—peripheral nervous system neoplasm	0.00325	0.00337	CcSEcCtD
Cisatracurium Besylate—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.00323	0.00336	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Vincristine—peripheral nervous system neoplasm	0.00323	0.00335	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Cisplatin—peripheral nervous system neoplasm	0.00322	0.00335	CcSEcCtD
Cisatracurium Besylate—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00321	0.00334	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.00313	0.00325	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Cisplatin—peripheral nervous system neoplasm	0.00311	0.00323	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.0031	0.00323	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.0031	0.00323	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00306	0.00318	CcSEcCtD
Cisatracurium Besylate—Flushing—Cisplatin—peripheral nervous system neoplasm	0.00294	0.00305	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.00286	0.00297	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00285	0.00296	CcSEcCtD
Cisatracurium Besylate—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.0028	0.00291	CcSEcCtD
Cisatracurium Besylate—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00279	0.0029	CcSEcCtD
Cisatracurium Besylate—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00279	0.0029	CcSEcCtD
Cisatracurium Besylate—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00277	0.00287	CcSEcCtD
Cisatracurium Besylate—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00277	0.00287	CcSEcCtD
Cisatracurium Besylate—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00275	0.00286	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.00273	0.00284	CcSEcCtD
Cisatracurium Besylate—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00273	0.00284	CcSEcCtD
Cisatracurium Besylate—Convulsion—Vincristine—peripheral nervous system neoplasm	0.0027	0.00281	CcSEcCtD
Cisatracurium Besylate—Flushing—Etoposide—peripheral nervous system neoplasm	0.00269	0.0028	CcSEcCtD
Cisatracurium Besylate—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00269	0.0028	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00264	0.00274	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.00263	0.00273	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.00262	0.00272	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.00261	0.00272	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00259	0.00269	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00259	0.00269	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00258	0.00268	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00257	0.00267	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00257	0.00267	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00256	0.00266	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00254	0.00264	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00253	0.00263	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00249	0.00259	CcSEcCtD
Cisatracurium Besylate—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00248	0.00258	CcSEcCtD
Cisatracurium Besylate—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00247	0.00256	CcSEcCtD
Cisatracurium Besylate—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00246	0.00256	CcSEcCtD
Cisatracurium Besylate—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00246	0.00256	CcSEcCtD
Cisatracurium Besylate—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00243	0.00253	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.00243	0.00252	CcSEcCtD
Cisatracurium Besylate—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00239	0.00248	CcSEcCtD
Cisatracurium Besylate—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00238	0.00247	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00235	0.00245	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00233	0.00242	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00225	0.00234	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.00225	0.00233	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.00223	0.00232	CcSEcCtD
Cisatracurium Besylate—Rash—Topotecan—peripheral nervous system neoplasm	0.00221	0.0023	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00221	0.0023	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.0022	0.00229	CcSEcCtD
Cisatracurium Besylate—Rash—Tretinoin—peripheral nervous system neoplasm	0.0022	0.00228	CcSEcCtD
Cisatracurium Besylate—Rash—Isotretinoin—peripheral nervous system neoplasm	0.0022	0.00228	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00219	0.00228	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00219	0.00228	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00219	0.00228	CcSEcCtD
Cisatracurium Besylate—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00219	0.00227	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00218	0.00227	CcSEcCtD
Cisatracurium Besylate—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00218	0.00226	CcSEcCtD
Cisatracurium Besylate—Rash—Melphalan—peripheral nervous system neoplasm	0.00217	0.00225	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00216	0.00225	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00213	0.00222	CcSEcCtD
Cisatracurium Besylate—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.0021	0.00218	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.0021	0.00218	CcSEcCtD
Cisatracurium Besylate—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.0021	0.00218	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.00207	0.00215	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.00207	0.00215	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00206	0.00214	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00201	0.00209	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.002	0.00208	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.002	0.00208	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00194	0.00202	CcSEcCtD
Cisatracurium Besylate—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00192	0.002	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.00192	0.00199	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00187	0.00195	CcSEcCtD
Cisatracurium Besylate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00187	0.00194	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00184	0.00191	CcSEcCtD
Cisatracurium Besylate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00179	0.00187	CcSEcCtD
Cisatracurium Besylate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00166	0.00173	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00166	0.00173	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00166	0.00172	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00165	0.00172	CcSEcCtD
Cisatracurium Besylate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00164	0.0017	CcSEcCtD
Cisatracurium Besylate—Rash—Vincristine—peripheral nervous system neoplasm	0.0016	0.00167	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.0016	0.00166	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.0016	0.00166	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.00153	0.00159	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00152	0.00158	CcSEcCtD
Cisatracurium Besylate—Flushing—Epirubicin—peripheral nervous system neoplasm	0.00151	0.00157	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.00148	0.00154	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.00147	0.00153	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.00147	0.00153	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00146	0.00152	CcSEcCtD
Cisatracurium Besylate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00146	0.00151	CcSEcCtD
Cisatracurium Besylate—Rash—Cisplatin—peripheral nervous system neoplasm	0.00142	0.00147	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00142	0.00147	CcSEcCtD
Cisatracurium Besylate—Erythema—Epirubicin—peripheral nervous system neoplasm	0.00141	0.00147	CcSEcCtD
Cisatracurium Besylate—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.0014	0.00145	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.00136	0.00142	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00136	0.00141	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00136	0.00141	CcSEcCtD
Cisatracurium Besylate—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00131	0.00136	CcSEcCtD
Cisatracurium Besylate—Rash—Etoposide—peripheral nervous system neoplasm	0.0013	0.00135	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.0013	0.00135	CcSEcCtD
Cisatracurium Besylate—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.00123	0.00127	CcSEcCtD
Cisatracurium Besylate—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.00122	0.00127	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.0012	0.00124	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00115	0.0012	CcSEcCtD
Cisatracurium Besylate—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.00113	0.00118	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.00113	0.00118	CcSEcCtD
Cisatracurium Besylate—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.00113	0.00117	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00113	0.00117	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00117	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.00111	0.00115	CcSEcCtD
Cisatracurium Besylate—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00108	0.00112	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.00111	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00105	0.00109	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00108	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00108	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00107	CcSEcCtD
Cisatracurium Besylate—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000998	0.00104	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000952	0.00099	CcSEcCtD
Cisatracurium Besylate—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000917	0.000953	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000851	0.000884	CcSEcCtD
Cisatracurium Besylate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000849	0.000882	CcSEcCtD
Cisatracurium Besylate—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000817	0.000849	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000787	0.000818	CcSEcCtD
Cisatracurium Besylate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000756	0.000786	CcSEcCtD
Cisatracurium Besylate—Rash—Epirubicin—peripheral nervous system neoplasm	0.000728	0.000757	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000727	0.000756	CcSEcCtD
Cisatracurium Besylate—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000674	0.0007	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000673	0.000699	CcSEcCtD
